HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SLSN

Solesence, Inc. (NASDAQ)

Consumer Defensive — Household & Personal Products

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

None
$0.73
+$0.00 (+0.15%)
Sign in to add SLSN to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$51.64M
P/E Ratio (TTM)73.11
Forward P/E-
EPS (TTM)$0.01
Dividend Yield-
Profit Margin1.56%
Revenue Growth-11.40%
ROE5.88%
Debt/Equity131.33
Recommendation None
Analyst Target-
Analysts-
Indexes NASDAQ

Technical Indicators

RSI (14)24.6
Beta1.24
SMA 20-
SMA 40-
52-Week High$4.55
52-Week Low$0.70
50-Day Avg$1.23
200-Day Avg$1.84
Avg Volume76.2K
Volume669

Performance Analysis

NEUTRAL

SLSN presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($0.70), which could present a value opportunity.
+ RSI at 24.6 signals oversold conditions — a bounce may be ahead.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- P/E of 73.1 is elevated — the market expects high growth or it may be overvalued.
- Revenue declined 11.4% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:31 UTC

Back to Screener Export Report